The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Myovant Sciences Ltd(NYSE:MYOV) 
Myovant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for women's health and endocrine diseases. The company's lead product is relugolix, an oral, once-daily, small molecule that acts as a gonadotropin-releasing hormone receptor antago...
Website: http://myovant.com
Founded: 2016
Full Time Employees: 407 (May 2021)
Sector: Healthcare
Industry: Biotechnology
Myovant Sciences Days Payable Outstanding ttm (DPO)
Myovant Sciences Days Receivable Outstanding ttm (DSO)
Myovant Sciences Days Inventory Outstanding ttm (DIO)
Myovant Sciences Op Cashflow Per Share ttm
Myovant Sciences Free Cashflow Per Share ttm
Myovant Sciences Cash Per Share ttm
Myovant Sciences P/S ratio ttm
Myovant Sciences (GAAP) P/E ratio ttm
Myovant Sciences P/B ratio ttm
No extra charts and metrics for this ticker.